SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Afify O, Suleiman ARM, Mohamed HG, Saaed O. BMJ Case Rep. 2021; 14(5): e241905.

Copyright

(Copyright © 2021, BMJ Publishing Group)

DOI

10.1136/bcr-2021-241905

PMID

33980559

PMCID

PMC8118060

Abstract

Visine eye drops are a commonly used topical drug for irritation of the eye. The active component in Visine eye drops is tetrahydrozoline. Tetrahydrozoline is an imidazoline derivative found in several ophthalmic and nasal decongestants. Exposure is common in young children, who unintentionally ingest it, but cases have been rising in the adult population. The main systemic effects are bradycardia and hypotension due to activation of the central alpha-adrenergic receptors. In this case report, a 76-year-old man presents with bradycardia after 24 hours following ingestion of 120 mL of 0.05% tetrahydrozoline (eight bottles of Visine eye drops) in a suicide attempt. His initial ECG demonstrated complete heart block and QT prolongation. Subsequent ECGs showed unremitting first-degree atrioventricular block and QT prolongation. Here, we are presenting the first case of complete heart block following tetrahydrozoline consumption.


Language: en

Keywords

Humans; Child; Adult; Child, Preschool; Aged; Male; poisoning; Electrocardiography; Eating; toxicology; arrhythmias; Atrioventricular Block; drug misuse (including addiction); Imidazoles; Ophthalmic Solutions

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print